BioAtla, Inc. (NASDAQ: BCAB) reported Q4 EPS of ($0.16), $0.06 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $2 million.

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.